IBX — Imagion Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00- AU$2.62m
- AU$2.79m
- AU$1.17m
Annual cashflow statement for Imagion Biosystems, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.2 | 2.63 | 2.55 | 3.6 | 0.368 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.62 | -5.07 | -8.07 | -8.32 | -1.27 |
| Capital Expenditures | -0.008 | -0.31 | -0.507 | -0.19 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.039 | 0 | 0.084 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.008 | -0.31 | -0.469 | -0.19 | 0.084 |
| Financing Cash Flow Items | -1.11 | -0.006 | 0 | -0.619 | -0.192 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.5 | 5.15 | -0.962 | 4.29 | 3.61 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.8 | 0.193 | -8.95 | -4.22 | 2.44 |